in PAT2 (EC 2.4.2.18) activity, and are therefore unable to convert anthranilate to PR-anthranilate. These plants have a number of interesting and potentially useful characteristics. For example, the trpl plants are blue fluorescent under UV light because they accumulate anthranilate compounds. The trpl-1 plants are also small and bushy, consistent with a defect in IAA biosynthesis.
We have isolated and characterized the A. thaliana PATI gene, the first PR-anthranilate transferase gene from a plant to be cloned and analyzed. PATI appears to be a single-copy gene, unlike the previously described aromatic amino acid biosynthetic genes. The PATI gene complements and is genetically linked to trpl mutations, consistent with the hypothesis that trpl alleles are PATI structural gene defects. The PATI gene, together with the trpl plants, will add to the growing collection of molecular tools available for the manipulation and study of A. thaliana.
The tryptophan biosynthetic pathway is the source of many important compounds in plants. In addition to its role in protein synthesis, this pathway provides precursors for a variety of indolic secondary products. These include the plant growth regulator auxin (IAA) (36) , antimicrobial phytoalexins (32) , alkaloids, and glucosinolates (15) .
Relatively little is known about the regulation of tryptophan biosynthesis in plants, although this pathway has been studied extensively in microorganisms. The pathway itself, shown in Figure 1 , is identical in all microorganisms studied to date, and the hypothesis that plants will utilize the same set of reactions is supported by biochemical analysis (reviewed in refs. 3 and 30) . Also, all of the existing plant tryptophan mutants have biochemical lesions in steps found in the microbial pathway (21, 22, 36) . However, a definitive statement that Figure 1 represents the in vivo plant pathway will not be possible until all steps are defined by mutation and/or analysis of the plant genes.
The tryptophan-requiring trpl-1 mutant of Arabidopsis thaliana was the first described plant amino acid auxotroph in which the auxotrophy shows Mendelian inheritance (22) . 
MATERIALS AND METHODS

Plant Methods
Arabidopsis thaliana ecotype Columbia was grown on agar medium or soilless mix as described (21, 22) . Standard methods were used to isolate plant DNA (6) and total RNA (12) .
DNA Manipulations
Plasmids were constructed using enzymes from New England Biolabs or Promega according to the recommendations of the manufacturers. Escherichia coli strains JM109 and NM538 were used for plasmid and bacteriophage lambda propagation, respectively. Single-stranded DNA was sequenced using the Multiwell Microtitre Plate DNA Sequencing System (Amersham). pNN423, which contains an A. thaliana cDNA capable of suppressing an E. coli trpD-mutation, was isolated as previously described by Elledge and coworkers (13) and was provided by John Mulligan (Stanford University). The entire cDNA insert in pNN423 was sequenced by subcloning re- striction fragments into pBluescript KS(+) (Stratagene). We also determined the sequence of several hundred nucleotides from the ends of three other PATI cDNAs isolated as plasmids that suppress E. coli trpD-. The GenBank and EMBL protein data bases were searched using the FASTA algorithm (27) .
A genomic clone (XAR1-5) that was obtained from an A. thaliana library (Clonetech) in XEMBL3 by plaque hybridization using pNN423 as a probe (28) was characterized. Fragments that cross-hybridize to the PAT1 cDNA were subcloned as follows. pAR1 19, which contains an 8.6-kb Sall fragment cloned into KS(+), was digested with BamHI, releasing a 4.1-kb BamHI-SalI genomic fragment with 45 bp of the KS(+) polylinker. pAR125 and pAR134 contain this 4.1-kb BamHI fragment in pGEM7Zf(+) (Promega) in opposite orientations. For sequence analysis, nested unidirectional deletions were generated from ClaI-and KpnI-digested pAR125 and pAR134 DNA by a method modified from that of Henikoff (17) , which involves treatment with exonuclease III followed by mung bean nuclease (New England Biolabs). The complete sequence of both strands of the 4.1 -kb fragment was determined and submitted to GenBank (accession No. M96073).
Plasmid pAR134A74, a deletion derivative of pAR134 that retains PATI nucleotides 1 to 1247 (numbering as in Fig. 5 ), was used to generate the probe for RNase protection experiments. The primer extension control plasmid pAR163 contains a 253-bp ScaI-XhoI fragment from pAR134A74, includ- L . c a . Figure 4 in the binary vector pEND4K (20) . Each of these plasmids was introduced into Agrobacterium tumefaciens strain LBA4404 by electroporation. The resulting strains were used to transform trpl-1 and trpl-100 (see below) A. thaliana mutants to kanamycin resistance as described (21, 33) , with the following modifications. Media contained 50 gM tryptophan, and selection against the A. tumefaciens was with 50 mg of carbenicillin/L. Shoots were induced to form roots on rooting medium (9) . Blue lightinduced photochemical degradation was reduced by filtration with yellow plexiglass filters (Polycast 2208, Curbell) as described (31) ylanthranilate, a compound that wild-type plants convert to toxic 5-methyltryptophan (22) , but differs from the trpl-1 plants in important ways. Unlike trpl-1, the trpl-100 plants do not require exogenous tryptophan for growth on defined medium, and they have normal growth morphology and fertility, as shown in Figure 2 . The trpl-100 plants are less fluorescent than trpl-1 plants, and this difference becomes more pronounced with age.
Genetic and biochemical analysis indicates that the trpl-1 and trpl-100 mutations are allelic. The F1 progeny of crosses between trpl-1 and trpl-100 are blue fluorescent, indicating that the mutations cannot complement each other. Furthermore, all 568 of the F2 progeny derived by self pollination of the F1 plants are blue fluorescent, confirming that the two mutations are tightly linked. Enzyme assays showed that both trpl-1 and trpl-100 plants are defective in PAT activity (22, and J. Li and R. Last, unpublished results).
Isolation of the PATI Gene
We sought to isolate a gene encoding PAT from A. thaliana because trpl mutant plants are known to be defective in this enzyme. A. thaliana cDNA clones capable of suppressing an E. coli trpD-PAT mutation were previously identified (13) . We determined the complete double-strand sequence of the insert in pNN423 and partial sequences of several other suppressing cDNAs. These cDNAs differ in length at the 5' end but are otherwise identical throughout the regions analyzed. We concluded that all were derived from the same gene and compiled a 1.6-kb composite cDNA sequence for further analysis.
The amino acid sequence of the only large open reading frame in this cDNA sequence (444 residues, predicted Mr of 46,517) is that of a PAT protein. Alignment of the A. thaliana amino acid sequence with a variety of microbial PATs is shown in Figure 3 . Compared individually with each PAT enzyme, the A. thaliana protein has 33 to 40% identical residues and an additional 38 to 42% analogous amino acids, for a total similarity of 73 to 81%. This similarity extends over the length of the microbial proteins and includes several blocks of highly conserved amino acids. There is a single tryptophan codon in the PAT1 coding region, consistent with the scarcity of tryptophan residues in the tryptophan biosynthetic enzymes of most organisms (8) . The A. thaliana protein has an amino-terminal extension of approximately 105 amino acids that is not found in the microbial proteins. This region has properties common to plastid leader peptides (34), including an abundance of seine and threonine residues and a net positive charge. Based on the ability to suppress the E. coli mutation and the similarity in predicted protein sequence, we named the gene from which the cDNAs were derived PATI.
Evidence for a Single PAT Gene
The PATI cDNA was used as a probe for A. thaliana genomic Southern blot analysis. As shown in Figure 4B , the only fragments that hybridize are those expected for the analysis. Primer extension products from 5' end-labeled ARP1 oligonucleotide annealed to 10 jug of tRNA, 10 ,ug of A. thaliana total RNA, or in vitro-synthesized PAT1 RNA from pAR163 were separated in a denaturing 8% polyacrylamide gel. Sequencing reactions with pAR1 34A74 template and the ARP1 primer are labeled to reflect the coding strand shown in Figure 5 . (18, 19, 21, 26 ). An independent method was used to search for functional homologs of PATI. A total of 81 A. thaliana cDNA clones that were capable of suppressing PAT mutations of E. coli were isolated as described (13) and screened by colony hybridization or restriction enzyme analysis. All 81 cDNAs hybridize strongly to the PATI cDNA or contain a common internal 0.8-kb PstI restriction fragment that is present in the PATI cDNAs. These results suggest that the cDNAs were all derived from the PATI gene. Our working hypothesis is that PATI is a single-copy gene, based on the lack of evidence for any other gene encoding PAT.
Characterization of the PATI Gene
The PATI cDNA was used as a probe to isolate genomic clones from an A. thaliana lambda library. Figure 4A . The DNA sequence of the 4.1-kb SallBamHI fragment containing the PATI gene is shown in Figure  5 . Comparison with the cDNA sequence indicates that the PATI gene consists of nine exons 60 to 273 bp long, separated by eight introns ranging in size from 78 to 352 bp. Each intron is bounded by conserved GT and AG dinucleotides (2) . The 5' ends of the PATI mRNA were mapped by primer extension and RNase protection experiments. The major primer extension product, indicated by the arrowhead in Figure 6A , maps to position 1126, 41 Figure 6A , reverse transcriptase synthesizes the expected full-length fragment from pAR163 RNA template, suggesting that the major band in the A. thaliana RNA template reaction is derived from the 5' end of the PATI mRNA. Fig. 4A ) were introduced into both trpl-1 and trpl-100 plants by A. tumefaciens-mediated transformation, with selection for kanamycin resistance conferred by the nptlI gene present in the vector. Kanamycin-resistant progeny, derived by self pollination of the original transformed plants, were screened for blue fluorescence and tryptophan auxotrophy. The presence of the PATI transgene was confirmed by genomic Southern blot analysis (data not shown). The PATI transgenes complement both trpl mutations. As summarized in Table I and Figure 7 , transgenic plants containing any of the three PATI fragments are no longer blue fluorescent. The trpl-l plants became prototrophic with wildtype morphology and fertility upon introduction of the PATI gene. In contrast, transformation with the pEND4K vector did not reverse the trpl phenotypes. All 62 vector-transformed trpl-l plants had the bushy, infertile phenotype of the trpl-1 parents, precluding progeny analysis. The kanamycin-resistant progeny of trpl-100 plants transformed with pEND4K remained blue fluorescent, showing that the loss of fluorescence was not due to the transformation procedure.
The complementing activity in the transformed plants is genetically linked to kanamycin resistance. Many transformants give rise to roughly one-quarter blue-fluorescent and kanamycin-sensitive progeny, as expected if the plants are heterozygous for the dominant PATI and nptII genes at a single locus. All of the blue-fluorescent progeny in these segregating populations are kanamycin sensitive, and none of the kanamycin-resistant plants are blue fluorescent. This demonstrates the tight linkage between the PATi and nptll genes expected if both genes are contiguous in the transferred DNA. It also confirms that the PATI gene is correcting all of the phenotypes associated with both the trpl-1 and trpl-100 mutations, rather than a trpl reversion or a tissue culture artifact.
RFLP mapping was also used to support the idea that PATI is the gene defective in trpl mutant plants. The Columbia (Col-0) and Landsberg erecta (Ler) ecotypes of A. thaliana differ in the length of an EcoRV fragment that hybridizes to the PATI gene (3.9 kb in Col-0, 4.8 kb in Ler). The trpl100coCo plants were crossed to TRP1Ler plants, and subsequent self-crossed generations were analyzed. After scoring the plants for blue fluorescence, genomic DNA was isolated from F3 progeny of 30 individual F2 plants. These DNAs were digested with EcoRV and subjected to Southem blot analysis using the PATI gene as a probe. In all cases, the TRP1 locus cosegregated with the PAT1 RFLP; the Col-0 3.9-kb fragment was found in all blue-fluorescent plants, the Ler 4.8-kb fragment was in the true-breeding nonfluorescent plants, and both bands were present in heterozygous populations.
The linkage of the trpl mutation and the PATI gene was confirmed by independent genetic means. RFLP mapping (performed in the laboratory of E. Meyerowitz) placed the PATI gene at position 32.2 on chromosome 5, 5.4 map units from the tt4 mutation (or CHS gene, see Fig. 8 ). If the trpl mutations are in the PATI gene, we would expect very few recombinants from a cross between tt4 and trpl plants.
To test this hypothesis, blue-fluorescent F2 plants from a tt4 x trpl-100 cross were scored for yellow seeds, characteristic of homozygous tt4 plants. If trpl-100 is 5.4 map units from tt4, we expect one in every 340 trpl-100 homozygotes to be homozygous for tt4. No tt4/tt4 plants were found out of 121 blue-fluorescent (trpl-100/trpl-100) F2 plants screened (Table II ), confirming that trpl-100 is linked to tt4, and supporting the idea that the trpl-100 mutation is in the PATI gene. The other recessive markers in this cross, gil and er, segregated as expected for unlinked genes (Table II) . The absence of trpl-100; tt4 double homozygotes could be due to a synthetic lethal interaction between flavonoid (tt) and tryptophan biosynthetic mutations rather than genetic linkage. This hypothesis was tested in a control cross between tt5, an unlinked flavonoid biosynthetic mutation on chromosome 3 (29) , and trpl-100 plants. Approximately onequarter of the blue-fluorescent F2 plants had yellow seeds (Table II) , as expected for unlinked markers.
DISCUSSION
Here we report the isolation of the A. thaliana PATI gene and show by complementation and mapping that it is the gene defective in trpl mutant plants.
Amino acid sequence comparisons confirm that PATI encodes a PAT. The most highly conserved block of amino acids (residues 181-189 of the A. thaliana sequence) has been implicated by mutational analysis as a phosphoribosyl pyrophosphate binding site (10) , and is similar to the Walker consensus sequence for nucleotide binding (35) . Although most of the highly conserved amino acids in microbial PATs are also found in the A. thaliana protein, a few are not. The glutamine, methionine, and glycine residues at positions 213, 285, and 336 of the A. thaliana sequence are histidine, leucine, and threonine residues, respectively, in the other PATs shown in Figure 2 .
The presence of a putative plastid leader sequence suggests that the mature PAT protein is localized to the chloroplast, the presumed site of tryptophan synthesis (3, 30) . Other enzymes in the aromatic amino acid pathways, such as 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase, 5-enolpyruvylshikimate-3-phosphate synthase, and tryptophan synthase A, have similar leader sequences and were shown biochemically to be present in chloroplasts (11, 14, 21, 25) .
Not all of the cDNAs analyzed encode the full leader sequence. Although we cannot rule out that these clones were derived from functional mRNAs that encode nonplastid targeted enzymes, we favor the hypothesis that these are incomplete cDNAs. The first in-frame initiation codon in these cDNAs is at nucleotide 2236 in exon 4. Thus, these clones would encode a truncated PAT enzyme that is missing a significant region of similarity to the microbial enzymes. The translational initiation of these cDNA clones in E. coli is almost certainly mediated by an ATG adjacent to the insert in the XYES vector (13) .
In many microorganisms, the enzymes catalyzing two different reactions in the tryptophan pathway are fused into bifunctional proteins (7). For example, the E. coli trpD gene encodes a fusion of PAT THE PATI GENE OF ARABIDOPSIS microbial mutations exist and will facilitate the analysis of functional domains of the plant proteins.
PATI seems to be the exception to the rule that A. thaliana aromatic amino acid biosynthetic enzymes are encoded by more than one gene. Another enzyme that is apparently encoded by a single gene in A. thaliana is acetolactate synthase (23) , which catalyzes the first common step in the biosynthesis of leucine, isoleucine, and valine. There are several unlikely ways in which our screen for a second PAT gene could have failed. A widely divergent but functionally redundant gene that is poorly represented in the cDNA library or is nonfunctional in E. coli might have been missed in a screen for cDNAs encoding PAT activity. Altematively, a recent duplication may have resulted in two PAT-containing chromosomal segments over 14 kb in length with identical restriction maps for the seven enzymes tested. The ability to isolate recessive trpl mutations suggests that PATI is single copy, or that a second gene, if present, either provides very little PAT activity or is expressed in different tissues than PATI.
The trpl-1 and trpl-100 plants differ in growth habit, fertility, and nutritional requirements. The fact that PAT1 complements all tested phenotypes of both mutants confirms the genetic evidence that these very different mutants have lesions in the same gene. The trpl-100 plants are much easier to work with than trpl-1 plants because even though they are blue fluorescent they grow normally and set seed well.
The trpl-1 and trpl-100 mutations are probably missense mutations that differ in the degree to which they impair PAT function. Experiments to test this hypothesis are in progress. The PAT1 gene, in conjunction with the trpl mutants, should prove to be a useful tool for the study of A. thaliana. Many of the techniques that allow sophisticated modifications of yeast, microbial, and even mammalian genomes are unavailable in plant molecular genetics. The antibiotic resistance genes currently employed have some disadvantages, such as allowing a relatively high number of individuals lacking the genes to escape selection. The small number of useful selectable markers currently available restricts the number of manipulations possible in a single strain. The PATI gene could serve as a marker in plant transformation, allowing selection in trpl-1 auxotrophs or screening for the loss of blue fluorescence in trpl-100 plants. PATI might also prove useful as a gene that can be selected against, as both trpl-1 and trpl-100 plants are resistant to 5-methylanthranilate (22, data not shown). Selection against a gene has been used to increase the recovery of transformants in which a DNA fragment has integrated by homologous recombination (4) .
Genes whose expression can be monitored visually, such as lacZ in E. coli or ADE2 in Saccharomyces cerevisiae, have proven valuable in a variety of applications such as genetic screens and recombination studies. The bacterial uidA gene, encoding /3-glucuronidase, is commonly used as a visible reporter to study tissue-specific promoter activity in plants, but detection usually requires a treatment that kills the sample. The PATI gene might serve as a visible reporter of gene expression because the presence or activity of PATI can be easily detected in whole living plants by screening for fluorescence.
